Related Experiment Video
Updated: Dec 9, 2025

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
RNA Splicing: Basic Aspects Underlie Antitumor Targeting
Alzahraa A M Fergany1, Victor V Tatarskiy2
1Department of Occupational and Environmental Health, Graduate School of Pharmaceutical Science, Tokyo University of Science, Chiba, Japan.
Background:
RNA splicing, a fundamental step in gene expression, is aimed at intron removal and ordering of exons to form the protein's reading frame.
Objective:
This review is focused on the role of RNA splicing in cancer biology; the splicing abnormalities that lead to tumor progression emerge as targets for therapeutic intervention.
Methods:
We discuss the role of aberrant mRNA splicing in carcinogenesis and drug response.
Results And Conclusion:
Pharmacological modulation of RNA splicing sets the stage for treatment approaches in situations where mRNA splicing is a clinically meaningful mechanism of the disease.
Insights
RNA splicing, a key gene expression process, is crucial in cancer. Aberrant splicing drives tumor progression and affects drug response, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- RNA splicing is essential for gene expression, involving intron removal and exon arrangement to create functional proteins.
- Aberrant RNA splicing is increasingly recognized as a significant factor in cancer development and progression.
Purpose of the Study:
- To review the critical role of RNA splicing in cancer biology.
- To highlight splicing abnormalities as potential therapeutic targets for cancer treatment.
Main Methods:
- Discussion of the literature on mRNA splicing in carcinogenesis.
- Analysis of the impact of aberrant splicing on patient response to cancer therapies.
Main Results:
- Aberrant mRNA splicing contributes to the initiation and advancement of various cancers.
- Splicing alterations can influence the efficacy of chemotherapy and targeted drug treatments.
Conclusions:
- Dysregulated RNA splicing is a clinically relevant mechanism in cancer.
- Targeting RNA splicing pharmacologically presents a promising avenue for novel cancer therapies.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Pre-mRNA Processing: RNA Splicing
Experimental RNAi
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

